Oxford, United Kingdom

Keith Martyn Dawson

USPTO Granted Patents = 8 

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 53(Granted Patents)


Location History:

  • Marlow, GB (1993 - 1997)
  • Oxford, GB (1997 - 1999)
  • Cowley, GB (1997 - 1999)

Company Filing History:


Years Active: 1993-1999

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Inventive Journey of Keith Martyn Dawson

Introduction:

Keith Martyn Dawson, a prolific inventor based in Oxford, GB, has made significant contributions in the field of biotechnology with a total of 8 patents to his name.

Latest Patents:

1. Disaggregated mutant human RANTES: Dawson's innovation focuses on mutants of human RANTES that exhibit reduced aggregation into large multimeric complexes, leading to lower pro-inflammatory responses compared to the wild-type molecule.

2. Modified plasmin precursors with resistance to inhibitors of plasmin: He has modified plasmin precursors to resist inhibitors, enhancing their fibrinolytic, thrombolytic, or antithrombotic properties for the treatment of blood clotting disorders.

Career Highlights:

Dawson has worked with renowned companies such as British Biotech Pharmaceuticals Limited and British Biotechnology Limited, driving innovation and research in the biotech industry.

Collaborations:

During his career, Dawson collaborated with esteemed coworkers like Michael George Hunter and Richard Mark Edwards, pooling their expertise to bring groundbreaking inventions to life.

Conclusion:

Keith Martyn Dawson's inventive spirit and dedication to advancing biotechnology have left a lasting impact on the industry, with his patents paving the way for new developments in medical treatments and therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…